Malaria Vaccines Market Market USD 134.9 million by 2026 | CAGR: 33.2%
Malaria Vaccines Market Size Worth USD 134.9 million by 2026
“According to Polaris Market Research report, Malaria Vaccines Market is witnessing major innovations & transformations and is anticipated to reach USD 134.9 million by 2026, registering a CAGR of 33.2% during the forecast period 2019 to 2026. The global Malaria Vaccines Market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2026 The market analysis covered in the report includes data in terms of value $134.9 Million. The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market.
Malaria Vaccines Market Report Scope: The global Malaria Vaccines Market is segmented based on vaccination type, agent, distribution channel and by region. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market.
-2-
Malaria Vaccines Market Size Worth USD 134.9 million by 2026
Agent Type Outlook
Vaccine Type Outlook
•
•
• •
Plasmodium Falciparum Plasmodium Vivax Anopheles Species
• •
• PreErythrocytic • • Vaccine Erythrocytic Vaccine Multiantigen Vaccine
Distribution Channel Outlook
By Region Type
Hospitals • Clinics • Community Centers • • •
North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
COVID-19 Impact Analysis for Malaria Vaccines Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its longterm effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Malaria Vaccines Market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities : Browse Detailed Research Report On Malaria Vaccines Market Analysis: https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market
Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service. Competitive Landscape The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a -3-
Malaria Vaccines Market Size Worth USD 134.9 million by 2026
detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Malaria Vaccines Market include GlaxoSmithKline, Nobelpharma, and Sanaria. Other promising vendors are Cadila Healthcare Ltd., VLP Therapeutics LLC, CellFree Sciences Co. Ltd., and Genome ReS Ltd. among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/malaria-vaccinesmarket/request-for-sample
Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4. Key take-away 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Malaria Vaccines Market Insights 3.1. Malaria Vaccines– Industry snapshot 3.2. Malaria Vaccines-Ecosystem analysis 3.3. Malaria Vaccines market dynamics 3.3.1.Malaria Vaccines– Market Forces 3.3.1.1. Malaria Vaccines Market driver analysis 3.3.1.2. Malaria Vaccines Market restraint/challenges analysis 3.3.1.3. Malaria Vaccines Market opportunity analysis 3.4. Industry analysis - Porter's five force 3.4.1.Bargaining power of supplier 3.4.2.Bargaining power of buyer 3.4.3.Threat of substitute 3.4.4.Threat of new entrant 3.4.5.Degree of competition 3.5. Malaria Vaccines market PEST analysis, 2017 3.6. Malaria Vaccines market Value Chain analysis 3.7. Malaria Vaccines Industry trends 3.8. Competitive Ranking Analysis 4. Malaria Vaccines Market Size and Forecast by Agent 4.1. Key Findings 4.2. Plasmodium Falciparum 4.2.1.Global Market Estimates and Forecasts, 2017-2026 4.3. Plasmodium Vivax 4.3.1.Global Market Estimates and Forecasts, 2017-2026 4.4. Anopheles Species 4.4.1.Global Market Estimates and Forecasts, 2017-2026 -4-
Malaria Vaccines Market Size Worth USD 134.9 million by 2026
5. Malaria Vaccines Market Size and Forecast by Vaccines Type 5.1. Key Findings 5.2. Pre-Erythrocytic Vaccine 5.2.1.Global Market Estimates and Forecasts, 2017-2026 5.3. Erythrocytic Vaccine 5.3.1.Global Market Estimates and Forecasts, 2017-2026 5.4. Multi-antigen Vaccine 5.4.1.Global Market Estimates and Forecasts, 2017-2026 6. Malaria Vaccines Market Size and Forecast by Channel of Distribution 6.1. Key Findings 6.2. Hospitals 6.2.1.Global Market Estimates and Forecasts, 2017-2026 6.3. Clinics 6.3.1.Global Market Estimates and Forecasts, 2017-2026 6.4. Community Centers 6.4.1.Global Market Estimates and Forecasts, 2017-2026 7. Malaria Vaccines Market Size and Forecast by Regions 7.1. Key findings 7.2. North America 7.2.1.Malaria Vaccines market by Agent, 2017 - 2026 7.2.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.2.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.2.4.U.S. 7.2.4.1. Malaria Vaccines market by Agent, 2017 - 2026 7.2.4.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.2.4.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.2.5.Canada 7.2.5.1. Malaria Vaccines market by Agent, 2017 - 2026 7.2.5.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.2.5.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.3. Europe 7.3.1.Malaria Vaccines market by Agent, 2017 - 2026 7.3.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.3.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 7.3.4.Germany 7.3.4.1. Malaria Vaccines market by Agent, 2017 - 2026 7.3.4.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 7.3.4.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8. 8.1. 8.1.1.UK 8.1.1.1. Malaria Vaccines market by Agent, 2017 - 2026 8.1.1.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.1.1.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.1.2.France 8.1.2.1. Malaria Vaccines market by Agent, 2017 - 2026 8.1.2.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.1.2.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.1.3.Asia Pacific 8.1.3.1. Malaria Vaccines market by Agent, 2017 - 2026 8.1.3.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 -5-
Malaria Vaccines Market Size Worth USD 134.9 million by 2026
8.1.3.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.1.4.China 8.1.4.1. Malaria Vaccines market by Agent, 2017 - 2026 8.1.4.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.1.4.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.1.5.India 8.1.5.1. Malaria Vaccines market by Agent, 2017 - 2026 8.1.5.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.1.5.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.1.6.Japan 8.1.6.1. Malaria Vaccines market by Agent, 2017 - 2026 8.1.6.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.1.6.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.2. Latin America 8.2.1.Malaria Vaccines market by Agent, 2017 - 2026 8.2.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.2.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.2.4.Brazil 8.2.4.1. Malaria Vaccines market by Agent, 2017 - 2026 8.2.4.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.2.4.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.2.5.Mexico 8.2.5.1. Malaria Vaccines market by Agent, 2017 - 2026 8.2.5.2. Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.2.5.3. Malaria Vaccines market by Channel of Distribution, 2017 - 2026 8.3. Middle East & Africa 8.3.1.Malaria Vaccines market by Agent, 2017 - 2026 8.3.2.Malaria Vaccines market by Vaccines Type, 2017 - 2026 8.3.3.Malaria Vaccines market by Channel of Distribution, 2017 - 2026 9. Company Profiles 9.1. GlaxoSmithKline 9.1.1.Overview 9.1.2.Financials 9.1.3.Product Benchmarking 9.1.4.Recent Developments 9.2. Nobelpharma 9.2.1.Overview 9.2.2.Financials 9.2.3.Product Benchmarking 9.2.4.Recent Developments 9.3. Sanaria 9.3.1.Overview 9.3.2.Financials 9.3.3.Product Benchmarking 9.3.4.Recent Developments 9.4. Cadila Healthcare Ltd. 9.4.1.Overview 9.4.2.Financials 9.4.3.Product Benchmarking 9.4.4.Recent Developments 9.5. VLP Therapeutics LLC -6-
Malaria Vaccines Market Size Worth USD 134.9 million by 2026
9.5.1.Overview 9.5.2.Financials 9.5.3.Product Benchmarking 9.5.4.Recent Developments 9.6. CellFree Sciences Co. Ltd. 9.6.1.Overview 9.6.2.Financials 9.6.3.Product Benchmarking 9.6.4.Recent Developments 9.7. Genome ReS Ltd. 9.7.1.Overview 9.7.2.Financials 9.7.3.Product Benchmarking 9.7.4.Recent Developments Access Press Release on Malaria Vaccines Market: https://www.polarismarketresearch.com/pressreleases/malaria-vaccines-market
About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com
-7-